Search results for "ulcerative colitis."

showing 10 items of 233 documents

OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study

2021

Abstract Background The management of inflammatory bowel disease (IBD) has substantially changed in the last decades, both in relation to medical and surgical treatments. Aims Principal: To know the rate of surgery in a newly diagnosed IBD cohort within the first year after diagnosis. Secondary: To describe the type of surgeries and indications in this cohort, and to identify predictive factors for surgery (focused on intestinal resection) in these patients. Methods Prospective, population-based nationwide registry. Adult patients diagnosed with IBD -Crohn’s disease (CD) and ulcerative colitis (UC)- during 2017 in Spain were included and were followed-up for 1 year. Kaplan-Meier curves were…

Crohn's diseasemedicine.medical_specialtyThiopurine methyltransferasebiologybusiness.industrymedicine.medical_treatmentGastroenterologyGeneral MedicineBowel resectionmedicine.diseaseGastroenterologyInflammatory bowel diseaseUlcerative colitisAcute abdomenInternal medicineCohortbiology.proteinMedicinemedicine.symptombusinessAbscessJournal of Crohn's and Colitis
researchProduct

Physicians’ Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the S…

2019

<b><i>Background:</i></b> No data on European countries about knowledge and application of immunization strategies in patients with inflammatory bowel disease (IBD) are available. <b><i>Objectives:</i></b> We designed a questionnaire aimed at exploring these issues among Italian gastroenterologists dealing with adult and paediatric IBD. <b><i>Methods:</i></b> An anonymous, 24-item, questionnaire was sent via e-mail to all members of the Italian Group for the study of Inflammatory Bowel Disease. Three sets of questions were formulated: (1) Characteristics of respondents; (2) General opinions on the role of vaccines in IB…

Crohn’s diseaseAdultMaleHealth Knowledge Attitudes Practicemedicine.medical_specialtyAttitude of Health PersonnelCrohn’s disease; Safety; Ulcerative colitis; VaccinesDiseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesHumansMedicineIn patientPractice Patterns Physicians'ChildResponse rate (survey)Settore MED/12 - GastroenterologiaVaccinesCrohn's diseaseUlcerative colitibusiness.industryGastroenterologistsGastroenterologyMiddle AgedInflammatory Bowel Diseasesmedicine.diseaseUlcerative colitisdigestive system diseasesVaccinationCrohn's diseaseUlcerative colitisItalyImmunization030220 oncology & carcinogenesisFamily medicineFemaleImmunization030211 gastroenterology & hepatologySafetybusinessDigestion
researchProduct

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

2021

(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD—Crohn’s disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)—during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and…

Crohn’s diseasemedicine.medical_specialtyPopulationDiseaseInflammatory bowel diseasedigestive systemArticle03 medical and health sciences0302 clinical medicineInterquartile rangeinflammatory bowel diseaseInternal medicineEpidemiologyMedicineeducationCrohn’s disease epidemiology incidence inflammatory bowel disease ulcerative colitisulcerative colitisCrohn's diseaseeducation.field_of_studybusiness.industryIncidence (epidemiology)RGeneral Medicinemedicine.diseaseUlcerative colitisdigestive system diseasesCrohn's disease030220 oncology & carcinogenesisincidenceMedicine030211 gastroenterology & hepatologyepidemiologybusiness
researchProduct

Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standard…

2020

BACKGROUND AND AIMS: Restructuring activities have been necessary during the lockdown phase of the coronavirus disease 2019 (COVID-19) pandemic. Few data are available on the post-lockdown phase in terms of health-care procedures in inflammatory bowel disease (IBD) care, and no data are available specifically from IBD units. We aimed to investigate how IBD management was restructured during the lockdown phase, the impact of the restructuring on standards of care and how Italian IBD units have managed post-lockdown activities. METHODS: A web-based online survey was conducted in two phases (April and June 2020) among the Italian Group for IBD affiliated units within the entire country. We inv…

Crohn’s diseasemedicine.medical_specialtystandards of careCOVID-19; Crohn’s disease; Inflammatory bowel disease; standards of care; therapy; ulcerative colitis; COVID-19; Critical Pathways; Disease Management; Humans; Inflammatory Bowel Diseases; Italy; Pandemics; Public Health Surveillance; Quality of Life; Surveys and Questionnaires; Standard of CareInflammatory bowel diseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Public health surveillanceAmbulatory careSurveys and QuestionnairesPandemicmedicineHumansPublic Health SurveillanceDisease management (health)Intensive care medicinePandemicsulcerative colitisCrohn's diseasetherapybusiness.industryGastroenterologyDisease ManagementCOVID-19Standard of Caremedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisOncologyItalyCOVID-19; Crohn’s disease; Inflammatory bowel disease; standards of care; therapy; ulcerative colitis030220 oncology & carcinogenesisCritical PathwaysQuality of Life030211 gastroenterology & hepatologybusiness
researchProduct

Endoscopic confocal imaging.

2005

In vivo fluorescence endomicroscopy is a newly developed diagnostic tool enabling virtual in vivo histology of the mucosal layer during ongoing endoscopy. This review summarizes currently available data about the technique and clinical use of confocal endomicroscopy. Indications discussed include colorectal cancer evaluation, ulcerative colitis and surveillance, Barrett's esophagus, and detection of Helicobacter pylori infection in vivo.

Diagnostic ImagingPathologymedicine.medical_specialtyColorectal cancerGastrointestinal DiseasesConfocalEndoscopy GastrointestinalDiagnosis DifferentialConfocal imagingIn vivoEndomicroscopyMedicineHumansEsophagusIntestinal MucosaMicroscopy ConfocalHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsEquipment Designmedicine.diseaseUlcerative colitisdigestive system diseasesEndoscopymedicine.anatomical_structurebusinessClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct

Imaging techniques in inflammatory bowel disease: recent trends, questions and answers

2009

Summary Imaging techniques have undergone substantial progress in recent years and contribute significantly in the diagnosis of inflammatory bowel diseases in conjunction with patient history, clinical and laboratory examination. Modern cross-sectional imaging modalities such as computed tomography and magnetic resonance imaging allow an evaluation not only of the complete bowel wall of the small intestine, but also of extraluminal structures. They constitute a major diagnostic component in the initial workup, in stricturing or fistulizing disease and in suspected abscess. Transabdominal ultrasonography has been re-appreciated in these settings as an easy- and ready-to-use tool yielding rea…

Diagnostic Imagingmedicine.medical_specialtyContrast MediaColonoscopySensitivity and SpecificityInflammatory bowel diseaseChromoendoscopyDiagnosis DifferentialCrohn DiseasePredictive Value of TestsmedicineEndomicroscopyHumansMedical historyClinical Trials as TopicMicroscopy Confocalmedicine.diagnostic_testbusiness.industryGastroenterologyMagnetic resonance imagingColonoscopyGeneral MedicineInflammatory Bowel Diseasesmedicine.diseaseMagnetic Resonance ImagingUlcerative colitisPositron emission tomographyPositron-Emission TomographyColitis UlcerativeRadiologyTomography X-Ray ComputedbusinessGastroentérologie Clinique et Biologique
researchProduct

5-Aminosalicylsäure-assoziierte Pankreatitis

2008

Acute pancreatitis with severe belt-like upper abdominal pain developed within 1-4 weeks of starting medication in three patients (29-year-old man with ulcerative colitis; 43-year-old woman and 22-year-old woman with Crohn's disease) treated, for the first time, with 5-aminosalicylic acid (mesalazine), 500 mg three times daily. Concentrations of lipase initially were 545, 1182 and 3000 U/l, and of amylase 243, 449 and 129 U/l, respectively. Symptoms receded within a few hours after the drug had been discontinued, enzyme levels returning to normal in the course of the next 2-3 weeks. On repeating the drug in two of the patients, in lower dosage, the pancreatitis recurred within a few days. T…

Drugmedicine.medical_specialtybiologybusiness.industrymedia_common.quotation_subjectGeneral Medicinemedicine.diseaseGastroenterologyUlcerative colitischemistry.chemical_compoundMesalazinechemistryInternal medicineUpper abdominal painbiology.proteinMedicinePancreatitisAcute pancreatitisAmylaseLipasebusinessmedia_commonDMW - Deutsche Medizinische Wochenschrift
researchProduct

Inflammatory Bowel Diseases

1979

The endoscopic aspects of an inflammatory colon disease do not permit the differentiation of a nonspecific proctitis from a bacterial enterocolitis and an ulcerative proctitis.

Enterocolitismedicine.medical_specialtybusiness.industryInflammatory Bowel DiseasesDiseasePseudomembranous colitismedicine.diseaseGastroenterologyUlcerative colitisdigestive system diseasesIschemic colitisUlcerative proctitisInternal medicineMedicinemedicine.symptombusinessProctitis
researchProduct

Elevated serum eotaxin levels in patients with inflammatory bowel disease.

2002

OBJECTIVE: Eotaxin is a recently characterized chemokine with potent and selective chemotactic activity for eosinophils. Previous studies indicating that eosinophils accumulate and become activated in inflammatory bowel disease (IBD) led us to hypothesize that eotaxin is potentially involved in the pathophysiology of IBD and, therefore, that eotaxin would be increased in the serum of patients with IBD. The objective of this study was to test those assumptions. METHODS: We investigated 72 patients with IBD, 35 with ulcerative colitis, and 37 with Crohn’s disease. A total of 27 patients had active and 45 inactive disease; 26 were receiving corticosteroids. Eotaxin serum levels were determined…

EotaxinAdultChemokine CCL11Adolescentmedicine.medical_treatmentInflammatory bowel diseaseSeverity of Illness IndexPathogenesisLeukocyte CountPrednisoneReference ValuesmedicineHumansAgedHepatologybusiness.industryGastroenterologyrespiratory systemEosinophilMiddle Agedmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisdigestive system diseasesPathophysiologyEosinophilsmedicine.anatomical_structureCytokineChemokines CCImmunologyColitis Ulcerativebusinessmedicine.drugThe American journal of gastroenterology
researchProduct

P114 A screening tool for the early diagnosis of extraintestinal manifestations in inflammatory bowel disease: the EMAIL questionnaire

2020

Abstract Background Data on prevalence of extraintestinal manifestations (EIMs) in inflammatory bowel disease (IBD) range from 6% up to 47%. Recently, several red flags and questionnaires have been proposed for early diagnosis of articular manifestations. Our aim was to analyse the prevalence of EIMs in a single-centre prospective cohort, using a comprehensive questionnaire developed by our group to detect all EIMs (EMAIL questionnaire). Methods Patients with IBD attending our Clinic from November 2017 to January 2019 were interviewed using a two-part questionnaire, the first part for clinical-demographic data and the second part for EIMs. Patients positive to screening were referred for mu…

Erythema nodosumAnkylosing spondylitismedicine.medical_specialtyCrohn's diseasebusiness.industryGastroenterologySacroiliitisGeneral Medicinemedicine.diseaseUlcerative colitisInflammatory bowel diseaseInternal medicinePsoriasismedicinebusinessPyoderma gangrenosumJournal of Crohn's and Colitis
researchProduct